Of note, different studies indicate that an excessive percentage of hyperphosphorylated MARCKS is not only prevalent in colorectal cancer but also occurs in hepatocellular carcinoma, lung and breast cancer (Bickeböller et al. 2015; Chen et al. 2015; Yang et al. 2015). This evidence concerns the gene MARCKS and hepatocellular carcinoma.